Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome

Olivera Stojadinovic, Natalie Yin, Janin Lehmann, Irena Pastar, Robert Kirsner, Marjana Tomic-Canic

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Langerhans cells (LCs) are a specialized subset of epidermal dendritic cells they represent one of the first cells of immunologic barrier and play an important role during the inflammatory phase of acute wound healing. Despite considerable progress in our understanding of the immunopathology of diabetes mellitus and its associated comorbidities such as diabetic foot ulcers (DFUs), considerable gaps in our knowledge exist. In this study, we utilized the human ex vivo wound model and confirmed the increased epidermal LCs at wound edges during early phases of wound healing. Next, we aimed to determine differences in quantity of LCs between normal human and diabetic foot skin and to learn if the presence of LCs correlates with the healing outcome in DFUs. We utilized immunofluorescence to detect CD207+ LCs in specimens from normal and diabetic foot skin and DFU wound edges. Specimens from DFUs were collected at the initial visit and 4 weeks later at the time when the healing outcome was determined. DFUs that decreased in size by >50 % were considered to be healing, while DFUs with a size reduction of <50 % were considered non-healing. Quantitative assessment of LCs showed a higher number of LCs in healing when compared to non-healing DFU's. Our findings provide evidence that LCs are present in higher number in diabetic feet than normal foot skin. Healing DFUs show a higher number of LCs compared to non-healing DFUs these findings indicate that the epidermal immune barrier plays an important role in the DFU healing outcome and may offer new therapeutic avenues targeting LC in non-healing DFUs.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalImmunologic Research
Volume57
Issue number1-3
DOIs
StatePublished - Dec 1 2013

Fingerprint

Diabetic Foot
Langerhans Cells
Epidermis
Wound Healing
Skin
Wounds and Injuries
Fluorescent Antibody Technique
Comorbidity
Foot
Diabetes Mellitus

Keywords

  • Chronic wound
  • Diabetic foot ulcers
  • Epidermis
  • Langerhans cells

ASJC Scopus subject areas

  • Immunology

Cite this

Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome. / Stojadinovic, Olivera; Yin, Natalie; Lehmann, Janin; Pastar, Irena; Kirsner, Robert; Tomic-Canic, Marjana.

In: Immunologic Research, Vol. 57, No. 1-3, 01.12.2013, p. 222-228.

Research output: Contribution to journalArticle

@article{d168346ad0144f3c8411930f6b7216fa,
title = "Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome",
abstract = "Langerhans cells (LCs) are a specialized subset of epidermal dendritic cells they represent one of the first cells of immunologic barrier and play an important role during the inflammatory phase of acute wound healing. Despite considerable progress in our understanding of the immunopathology of diabetes mellitus and its associated comorbidities such as diabetic foot ulcers (DFUs), considerable gaps in our knowledge exist. In this study, we utilized the human ex vivo wound model and confirmed the increased epidermal LCs at wound edges during early phases of wound healing. Next, we aimed to determine differences in quantity of LCs between normal human and diabetic foot skin and to learn if the presence of LCs correlates with the healing outcome in DFUs. We utilized immunofluorescence to detect CD207+ LCs in specimens from normal and diabetic foot skin and DFU wound edges. Specimens from DFUs were collected at the initial visit and 4 weeks later at the time when the healing outcome was determined. DFUs that decreased in size by >50 {\%} were considered to be healing, while DFUs with a size reduction of <50 {\%} were considered non-healing. Quantitative assessment of LCs showed a higher number of LCs in healing when compared to non-healing DFU's. Our findings provide evidence that LCs are present in higher number in diabetic feet than normal foot skin. Healing DFUs show a higher number of LCs compared to non-healing DFUs these findings indicate that the epidermal immune barrier plays an important role in the DFU healing outcome and may offer new therapeutic avenues targeting LC in non-healing DFUs.",
keywords = "Chronic wound, Diabetic foot ulcers, Epidermis, Langerhans cells",
author = "Olivera Stojadinovic and Natalie Yin and Janin Lehmann and Irena Pastar and Robert Kirsner and Marjana Tomic-Canic",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s12026-013-8474-z",
language = "English",
volume = "57",
pages = "222--228",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1-3",

}

TY - JOUR

T1 - Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome

AU - Stojadinovic, Olivera

AU - Yin, Natalie

AU - Lehmann, Janin

AU - Pastar, Irena

AU - Kirsner, Robert

AU - Tomic-Canic, Marjana

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Langerhans cells (LCs) are a specialized subset of epidermal dendritic cells they represent one of the first cells of immunologic barrier and play an important role during the inflammatory phase of acute wound healing. Despite considerable progress in our understanding of the immunopathology of diabetes mellitus and its associated comorbidities such as diabetic foot ulcers (DFUs), considerable gaps in our knowledge exist. In this study, we utilized the human ex vivo wound model and confirmed the increased epidermal LCs at wound edges during early phases of wound healing. Next, we aimed to determine differences in quantity of LCs between normal human and diabetic foot skin and to learn if the presence of LCs correlates with the healing outcome in DFUs. We utilized immunofluorescence to detect CD207+ LCs in specimens from normal and diabetic foot skin and DFU wound edges. Specimens from DFUs were collected at the initial visit and 4 weeks later at the time when the healing outcome was determined. DFUs that decreased in size by >50 % were considered to be healing, while DFUs with a size reduction of <50 % were considered non-healing. Quantitative assessment of LCs showed a higher number of LCs in healing when compared to non-healing DFU's. Our findings provide evidence that LCs are present in higher number in diabetic feet than normal foot skin. Healing DFUs show a higher number of LCs compared to non-healing DFUs these findings indicate that the epidermal immune barrier plays an important role in the DFU healing outcome and may offer new therapeutic avenues targeting LC in non-healing DFUs.

AB - Langerhans cells (LCs) are a specialized subset of epidermal dendritic cells they represent one of the first cells of immunologic barrier and play an important role during the inflammatory phase of acute wound healing. Despite considerable progress in our understanding of the immunopathology of diabetes mellitus and its associated comorbidities such as diabetic foot ulcers (DFUs), considerable gaps in our knowledge exist. In this study, we utilized the human ex vivo wound model and confirmed the increased epidermal LCs at wound edges during early phases of wound healing. Next, we aimed to determine differences in quantity of LCs between normal human and diabetic foot skin and to learn if the presence of LCs correlates with the healing outcome in DFUs. We utilized immunofluorescence to detect CD207+ LCs in specimens from normal and diabetic foot skin and DFU wound edges. Specimens from DFUs were collected at the initial visit and 4 weeks later at the time when the healing outcome was determined. DFUs that decreased in size by >50 % were considered to be healing, while DFUs with a size reduction of <50 % were considered non-healing. Quantitative assessment of LCs showed a higher number of LCs in healing when compared to non-healing DFU's. Our findings provide evidence that LCs are present in higher number in diabetic feet than normal foot skin. Healing DFUs show a higher number of LCs compared to non-healing DFUs these findings indicate that the epidermal immune barrier plays an important role in the DFU healing outcome and may offer new therapeutic avenues targeting LC in non-healing DFUs.

KW - Chronic wound

KW - Diabetic foot ulcers

KW - Epidermis

KW - Langerhans cells

UR - http://www.scopus.com/inward/record.url?scp=84891486157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891486157&partnerID=8YFLogxK

U2 - 10.1007/s12026-013-8474-z

DO - 10.1007/s12026-013-8474-z

M3 - Article

C2 - 24277309

AN - SCOPUS:84891486157

VL - 57

SP - 222

EP - 228

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1-3

ER -